Antibiotic Prophylaxis for ASD Device Closure
For percutaneous ASD device closure, administer a single dose of cefazolin 2g IV (or vancomycin 30 mg/kg over 120 minutes for beta-lactam allergy) immediately before the procedure, with no continuation beyond the operative period.
Recommended Regimen
The standard prophylaxis protocol follows clean cardiac surgery guidelines 1:
- First-line: Cefazolin 2g IV slow push as a single dose
- Beta-lactam allergy: Vancomycin 30 mg/kg IV over 120 minutes (must complete infusion before or within 30 minutes of procedure start)
- Timing: Administer immediately before procedure
- Duration: Single dose only—do not extend beyond the operative period (maximum 24 hours)
- Re-dosing: If procedure exceeds 4 hours, give cefazolin 1g IV
Target Organisms
The prophylaxis targets S. aureus, S. epidermidis, and select gram-negative bacteria, which are the primary pathogens in cardiac device-related infections 1.
Evidence Supporting Single-Dose Approach
Recent large-scale data strongly supports minimal antibiotic use. A 2026 multicenter study analyzing 20,580 congenital cardiac catheterization procedures found that procedure-related infective endocarditis is exceedingly rare (0.07% overall, 0.04% for ASD closure specifically) 2. Critically, no measurable association existed between antibiotic prophylaxis dosing strategies and early infective endocarditis, with significant variation in practice patterns (38.8% to 85.7% of patients receiving ≥2 doses depending on procedure type) showing no impact on infection rates 2.
Critical Pitfalls to Avoid
Do not continue antibiotics beyond the operative period. The evidence demonstrates:
- Prolonged antibiotic courses provide no additional protection against endocarditis 2
- Extended prophylaxis promotes antibiotic resistance without clinical benefit 3
- Current guidelines increasingly restrict indications to promote rational antibiotic use 1, 3
Do not confuse periprocedural prophylaxis with post-device endocarditis prophylaxis. While older practices recommended 6 months of endocarditis prophylaxis after device placement, contemporary evidence does not support this approach for routine dental or other procedures 3.
Vancomycin-Specific Considerations
Use vancomycin specifically for 1:
- Documented beta-lactam allergy
- Known MRSA colonization
- Recent hospitalization in units with high MRSA prevalence
- Recent antibiotic therapy
The 120-minute infusion requirement is critical—infusion must complete at or ideally 30 minutes before procedure start to achieve adequate tissue levels 1.
Procedural Context
This recommendation applies to percutaneous device closure via femoral vein approach, which is now commonly performed under echocardiographic guidance without fluoroscopy 4. The procedure is classified as clean cardiac surgery (Altemeier class 1), justifying the single-dose prophylaxis approach 1.